연구동향 분석
박사

동기강화상담 기반 암환자의 복약관리프로그램 개발 및 효과평가 = The development and evaluation of motivational interviewing based medication management program for cancer patients taking oral anticancer agents

이연희 2015년

논문상세정보
인용/피인용
' 동기강화상담 기반 암환자의 복약관리프로그램 개발 및 효과평가 = The development and evaluation of motivational interviewing based medication management program for cancer patients taking oral anticancer agents' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • drug therapy
  • medication adherence
  • motivational interviewing
  • neoplasm
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
104 0

0.0%

' 동기강화상담 기반 암환자의 복약관리프로그램 개발 및 효과평가 = The development and evaluation of motivational interviewing based medication management program for cancer patients taking oral anticancer agents' 의 참고문헌

  • 암환자의 경구용 항암제 복약이행 영향요인
    이연희 정인숙 Asian Oncology Nursing, 13(4), 201-209 [2013]
  • 박사
    신장이식 환자의 면역억제제 복용이행
    정주희 大韓移植學會誌, 24(4), 289-297 [2010]
  • 대장암 환자의 경구용 항암제 복약이행과 영향요인
    김정혜 Asian Oncology Nursing, 12(3), 213-220 [2012]
  • 노인 암환자의 경구용 항암제 복약순응도. 서울대학교 석사학위논문
    최정실 서울 [2012]
  • 경구용 항암제 복용 이행에 대한 조사연구 서울대학교 석사학위논문
    이은령 서울 [2006]
  • 건강보험심사평가원., 09, 30). 암 환자에게 처방⋅투여하는 약제에 대한 요양급여의 적용기준 및 방법에 관한 세부사항
    Retrieved December 10., 2014. from http://www.hira.or.kr/dummy.do?pgmid=HIRAA030023010000 [2014]
  • 간암환자의 경구용 표적치료제(Sorafenib) 복용이행의 영향요인. 동아대학교 석사학위논문
    구나경 부산 [2014]
  • Yagasaki, K., Komatsu, H., & Takahashi, T. (2015). Inner conflict in patients receiving oral anticancer agents: a qualitative study. British of Medical Journal Open, 5(4), e006699.
  • World Health Organization. (2003). Adherence to long-term therapies: Evidence for actions. Geneva.
  • Wood, L. (2012). A review on adherence management in patients on oral cancer therapies. European Journal of Oncology Nursing, 16(4), 432-438. doi: http://dx.doi.org/10.1016/j.ejon.2011.10.002
  • Winkeljohn, D. L. (2007). Oral Chemotherapy Medications: The need for a nurse's touch. Clinical Journal of Oncology Nursing, 11(6), 793-6.
  • Winkeljohn, D. (2010). Adherence to oral cancer therapies: nursing interventions. Clinical Journal of Oncology Nursing, 14(4), 461-466.
  • Williams, A., Manias, E., Walker, R. (2008). Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. Journal of Advanced Nursing, 63(2), 132-143.
  • Weingart, S. N., Brown, E., Bach, P. B., EngK, Johnson, S. A., Kruzel, T. M. et al. (2008). NCCN task force report: oral chemotherapy. Journal of National Comprehensive Cancer Network, 132-143.
  • Weber S. (2012). Commercial plans seek more control over oral oncolytics. Managed Care Oncology, 2012(4), 8-22.
  • Waterhouse, D. M., Calzone, K. A., Mele, C., Brenner, D. E. (1993). Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology. 11(6), 1189-1197.
  • Viele, C. S. (2007). Managing oral chemotherapy: The healthcare practitioner’s role. American Journal of Health-System Pharmacy, 64(9) Supplement 5, S25-S32. doi: 10.2146/ajhp070037
  • Verbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., & Van Hecke, A. (2013). Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review. Cancer Treatment Reviews. 39(6), 610-21.
  • Verbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., & Van Hecke, A. (2013). Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review. Cancer Treatment Reviews, 39(6), 610-621.
  • Verbrugghe, M., Duprez, V., Beeckman, D., Grypdonck, M., Quaghebeur, M., Verschueren, C., Van Hecke, A. (2015). Factors influencing adherence in cancer patients taking oral tyrosine kinase inhibitors. Cancer Nursing. 2015 March 26. doi: 10.1097/NCC.0000000000000250
  • Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Christian, M. C. (2000). New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute, 92(3), 205-216.
  • Taplin, S. H., Barlow, W. E., Ludman, E., MacLehos, R., Meyer, D. M., Seger, D., Curry, S. (2000). Testing reminder and motivational telephone calls to increase screening mammography: a randomized study. Journal of the National Cancer Institute, 92(3), 233-242.
  • Spoelstra, S. L., Schueller, M., Hilton, M., & Ridenour, K. (2015). Interventions combining motivational interviewing and cognitive behaviour to promote medication adherence: a literature review. Journal of Clinical Nursing, 24(9-10), 1163-1173.
  • Spoelstra, S. L., Given, B. A., Given, C. W., Grant, M., Sikorskii, A., You, M., & Decker, V. (2013). Issues related to overadherence to oral chemotherapy or targeted agents. Clinical Journal of Oncology Nursing, 17(6), 604-609.
  • Spoelstra, S. L., & Given, C. W. (2011). Assessment and measurement of adherence to oral antineoplastic agents. Seminars in Oncology Nursing, 27(2), 116-132.
  • Sommers, R. M., Miller, K., Berry, D. L. (2012). Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer. Oncology Nursing Forum, 39(4), 373-379.
  • Simchowitz, B., Shiman, L., Spencer, J., Brouillard, D., Gross, A., Connor, M., & Weingart, S. N. M. D. P. (2010). Perceptions and experiences of patients receiving oral chemotherapy. Clinical Journal of Oncology Nursing, 14(4), 447-453. doi: 10.2146/ajhp070035
  • Siden, R., Kem, R., Ostrenga, A., Nicksy, D., Bernhardt, B., & Bartholomew, J. (2014). Templates of patient brochures for the preparation, administration and safe-handling of oral chemotherapy. Journal of Oncology Pharmacy Practice, 20(3), 217-224.
  • Shrank, W. H., Bhattarai, G. R., & Montague-Clouse, J. C. (2012). Outcomes of a specialty pharmacy program for oral oncology medications. American Journal of Pharmacy, 4(4), 165-174.
  • Shi, L., Lui, J., Koleva, Y., Fonseca, V., Kalsekar, A., & Pawaskar, M.(2010). Concordance of adherence measurement using self-reported adherence questionnaires and Medication Monitoring Devices. Pharmacoeconomics, 28(12), 1097-1107.
  • Schroeder, K., Fahey, T., Ebrahim, S. (2004). Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. The Cochrane Library.
  • Schmaling, K. B., Blume, A., & Afri, N. (2001). A randomized controlled pilot study of motivational interviewing to change attitudes about adherence to medications for asthma. Journal of Clinical Psychology in Medical Settings, 8, 167-72.
  • Schedlbauer, A., Davies, P., Fahey, T. (2010). Interventions to improve adherence to lipid lowering medication. Cochrane Database Systematic Review, 3(3).
  • Safren, S. A., Otto, M. W., Worth, J. L. et al. (2001). The strategies to increase adherence to HIV antiviral medication: life-steps and medication monitoring. Behaviour Research and Therapy, 39, 1151-62.
  • Ruppar, T. M., Conn, V. S., & Russell, C. L. (2008). Medication adherence interventions for older adults: literature review. Research and Theory for Nursing Practice, 22(2), 114-147.
  • Ruddy, K., Mayer, E., & Partridge, A. (2009). Patient adherence and persistence with oral anticancer treatment. Cancer Journal for Clinicians, 59(1), 56-66.
  • Ruback, S., Sandbaek, A., Lauritzen T., & Christensen B. (2005). Motivational interviewing: a systematic review and meta-analysis. British Journal of General Practice, 55(513), 305-312.
  • Roila, F., Lupattelli, M., Sassi, M., Basurto, C., Bracarda, S., Picciafuoco, M., Tonato, M. (1991). Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Annals of Oncology, 2(6), 437-439.
  • Riekert, K. A., Borrelli, B., Bilderback, A., & Rand, C. S. (2011). The development of a motivational interviewing intervention to promote medication adherence among inner-city, African-American adolescents with asthma. Patient Education and Counseling, 82(1), 117-122.
  • Resnicow, K., Jackson, A., Wang, T., De, A. K., McCarty, F., Dudley, W.N., & Baranowski, T. (2001). A motivational interviewing intervention to increase fruit and vegetable intake through Black churches: results of the Eat for Life trial. American journal of public health, 91(10), 1686-1693.
  • Regnier Denois, V., Poirson, J., Nourissat, A., JACQUIN, J. P., Guastalla, J., & Chauvin, F. (2011). Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists. European Journal of Cancer Care, 20(4), 520-527.
  • Patel, K., Foster, N., Farrell, A., Le-Lindqwister, N., Mathew, J., Costello, B., Jatoi, A. (2013). Oral cancer chemotherapy adherence and adherence assessment tools: a report from north central cancer group trial N0747 and a systematic review of the literature. Journal of Cancer Education, 1-7. doi: 10.1007/s13187-013-0511-z
  • Partridge, A. H., Wang, P. S., Winer, P. S., & Avorn, J. (2008). Nonadherence to adjuvant tamoxifen therapy in women with early stage breast cancer. Journal of Clinical Oncology. 21, 602-606.
  • Partridge, A. H., Avorn, J., Wang, P. S., & Winer, E. P. (2002). Adherence to therapy with oral antineoplastic agents. Journal of the National Cancer Institute, 94(9), 652-661. doi: 10.1093/jnci/94.9.652
  • Park, J., Jackson, J., Skinner, E., Ranghell, K., Saiers, J., & Cherney, B. (2010). Impact of an adherence intervention program on medication adherence barriers, asthma control, and productivity/daily activities in patients with asthma. Journal of Asthma, 47(10), 1072-1077.
  • Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487-497.
  • Orwig, D., Brandt, N., & Gruber-Baldini, A. L. (2006). Medication management assessment for older adults in the community. Gerontologist, 46(5), 661-668.
  • Oncology Nursing society. (2010). ONS toolkit helps patients adhere to oral therapies for cancer. Retrieved from Apirl, 10, 2014. https://www.ons.org/practice-resources/clinical-practice/ons-toolkit-helps-patients-adhere-oral-therapies-cancer
  • Ogedegbe, G., Schoenthaler, A., Richardson, T., Lewis, L., Belue, R., Espinosa, E., Charlson, M. E. (2007). An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: Rationale and design. Contemporary Clinical Trials, 28(2), 169-181.
  • Ogedegbe, G., Chaplin, W., Schoenthaler, A., Statman, D., Berger, D., Richardson, T., Allegrante, J. P. (2008). A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. American Journal of Hypertension, 21(10), 1137-1143.
  • O'Nell, V. J., & Twelves, C. J. (2002). Oral cancer treatment: development in chemotherapy and beyond. British Journal of Cancer. 87, 933-937.
  • Multinational Association of Supportive Cancer in Care (MASCC)(2008). MASCC Oral Agent Teaching Tool (MOATT). Retrieved from April, 10, 2014. http://www.mascc.org/MOATT
  • Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical hypertension. 10(5): 348-354.
  • Moore, S. (2007). Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nursing, 30(2), 112-122; quiz 123-114. doi: 10.1097/01.NCC.0000265009.33053.2d
  • Moon, J. H., Shon, S. S., Kim, S. H., Park, S. Y., Yoon, S. S., Kim, I. H. et al. (2012). Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients. Medical Oncology. 29, 1179-1185.
  • Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed). New York, NY: Guilford press.
  • Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Helping people change (2nd ed). New York, NY: Guilford press.
  • Miller, W. R. (2004). Motivational interviewing in service to health promotion. American Journal of Health Promotion, 18(3), A1-A10.
  • Miller, W .R. (1983). Motivational interviewing with problem drinkers. Behavioural Psychotherapy. 11: 147-172.
  • McDonald, H. P., Garg, A. X., & Haynes, R. (2002). Interventions to enhance patient adherence to medication prescriptions: Scientific review. Journal of American Medical Association, 288(22), 2868-2879. doi: 10.1001/jama.288.22.2868
  • Mayer, E., Partridge, A., Harris, L., Gelman, R., Schumer, S., Burstein, H., & Winer, E. (2009). Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast cancer research and treatment, 117(3), 615-623.
  • Matza L. S., Yu-Isenberg K. S., Coyne K. S., Park J., Wakefield J., Skinner E. P., & Wolever, Q., R. (2008). Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population. Current Medical Research and Opinion, 24(11), 3197-3206.
  • Matthews, J., & Caprera, P. H. (2014). Essentials of oral oncolytics: developing a nursing reference. Clinical Journal of Oncology Nursing, 18(5), E88-E92.
  • Mathes, T., Antoine, S. L., Pieper, D., & Eikermann, M. (2014). Adherence enhancing interventions for oral anticancer agents: a systematic review. Cancer Treatment Review, 40(1), 102-108.
  • Mars , H., Van Cutsem, E., Grothey, A., & Valverde, S. (2004). Management of adverse events and other practical considerations in patients receiving Capecitabine (Xeloda ). European Journal of Oncology Nursing, 8, Supplement 1(0), S16-S30.
  • Mahtani, K. R., Heneghan, C. J., Glasziou, P. P., Perera, R.(2011). Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Systematic Review. 9, cd005025. DOI:10.1002/14651858.CD005025.pub3
  • Macintosh, P., Pond, G., Pond, B., Leung, V., & Siu, L. (2007). A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes. European Journal of Cancer Care, 16(4), 380-386.
  • Lundahl, B., Moleni, T., Burke, B. L., Butters, R., Tollefson, D., Butler, C., & Rollnick, S. (2013). Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials. Patient Education and Counseling, 93(2), 157-168.
  • Levensky, E. R., Forcehimes, A., O'Donohue, W. T., & Beitz, K. (2007). Motivational interviewing: an evidence-based approach to counseling helps patients follow treatment recommendations. American Journal of Nursing, 107(10), 50-58. doi: 10.1097/01.naj.0000292202.06571.24
  • Leonard, R., Cameron, D., Anderson, A., Ostrowski, J., & Howell, A. (2000). Idarubicin and cyclophosphamide—an active oral chemotherapy regimen for advanced breast cancer. Critical reviews in oncology/hematology, 33(1), 61-66.
  • Lee, W.-Y., Ahn, J., Kim, J.-H., Hong, Y.-P., Hong, S. K., Kim, Y. T., Morisky, D. E. (2013). Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. Journal of International Medical Research, 41(4), 1098-1110. doi: 10.1177/0300060513484433
  • Lacasse, C. (2011). Polypharmacy and symptom management in older adults. Clinical Journal of Oncology Nursing, 15(1), 27-30.
  • Kripalani, S., Yao, X., & Haynes, R. B. (2007). Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Archives of Internal Medicine, 167(6), 540-549.
  • Kirk, M. C., & Hudis, C. A. (2008). Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clinical breast cancer, 8(2), 155-161.
  • Kav, S., Schulmeister, L., Nirenberg, A., Barber, L., Johnson, J., & Rittenberg, C. (2010). Development of the MASCC teaching tool for patients receiving oral agents for cancer. Supportive Care in Cancer, 18(5), 583-590.
  • Jabbour, E. J., Kantarjian, H., Eliasson, L., Megan, Cornelison, A., & Marin D. (2012). Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia. American Journal of Hematology. 87(7), 87-91.
  • Holstad, M., DiIorio, C., Kelley, M., Resnicow, K., & Sharma, S. (2011). Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV. Infected Women. AIDS and Behavior, 15(5), 885-896. doi:10.1007/s10461-010-9865-y
  • Hoiquist, C., & Phillips, J. (2003). Fatal medication errors associated with Temodar. Drug Topics, 7, 42.
  • Hiroaki Harai. 건강동기상담 전문가 핸드북 DVD(신수경, 조성희 역)
    서울 : 시그마프레스(original work published 2005) [2008]
  • Hettema, J., Steele, J., & Miller, W. R. (2005). Motivational interview. Annual Review of Clinical Psychology, 1, 91-111.
  • Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., Yao, X. (2008). Interventions for enhancing medication adherence. Cochrane database systematic Review, 2(2).
  • Hartigan, K. (2003). Patient education: The cornerstone of successful oral chemotherapy treatment. Clinical Journal of Oncology Nursing. 7(6), 21-24.
  • Harrold, K. (2010). Effective management of adverse effects while on oral chemotherapy: implications for nursing practice. European Journal of Cancer Care, 19, 12-20. doi: 10.1111/j.1365-2354.2010.01197.x
  • Hahn, S. R., Park, J., Skinner, E. P., Yu-Isenberg, K. S., Weaver, M., B., Crawford, B., & Flowers, P. W.(2008). Development of the ASK-20 adherence barrier survey. Current Medical Research and Opinion, 24(7), 2127-2138.
  • Grunfeld, E. A., Hunter, M. S., Sikka, P., & Mittal, S. (2005). Adherence beliefs among breast cancer patients taking tamoxifen. Patient Education and Counseling, 59(1), 97-102. doi: 10.1016/j.pec.2004.10.005
  • Given, B., Given, C., & Spoelstra, S. (2010). Intervention to improve adherence and symptoms from oral agents: final scientific report. Pittsburgh, PA: Oncology Nursing Society Foundation.
  • Given, B. A., Spoelstra, S. L., & Grant, M. (2011). The challenges of oral agents as antineoplastic treatments. Seminars in Oncology Nursing, 27(2), 93-103. doi: http://dx.doi.org/10.1016/j.soncn.2011.02.003
  • Geynisman D. M., & Wickersham, K. E. (2013). Adherence to targeted oral anticancer medications. Discovery medicine, 15(83), 231-241. doi: 10.2146/ajhp070038
  • Gebbia, V., Bellavia, G., Ferra , F., & Valerio, M. R. (2012). Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents. Expert opinion on drug safety, 11(S1), S49-S59.
  • Gater, A., Heron, L., Abetz-Webb, L., Coombs, J., Simmons, J., Guilhot, F., & Rea, D. (2012). Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia. Leukemia Research, 36(7), 817-825.
  • Gance-Cleveland, B. (2007). Motivational interviewing: improving patient education. Journal of Pediatric Health Care, 21(2), 81-88.
  • Foulon, V., Schoffski, P., Wolter, P. (2011). Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clinica Belgica 66(2), 85-96. doi:10.2143/ACB.66.2.2062525
  • Feld, R., Woodside, D. B., Kaplan, A. S., Olmsted, M. P., & Carter, J. C. (2001). Pretreatment motivational enhancement therapy for eating disorders: a pilot study. International Journal of Eating Disorders, 29(4), 393-400.
  • Faul, F., Erdfelder, E., Buchner, A., & Lang, A. G. (2009). Statistical poweranalyses using G* Power 3.1: Tests for correlation and regressionanalyses. Behavior research methods, 41(4), 1149-1160.
  • Farmer, A., Hardeman, W., Hughes, D., Prevost, A. T., Kim, Y., Craven,A., Kinmonth, A. L. (2012). An explanatory randomized controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Family Practice, 13, 30. doi: 10.1186/1471-2296-13-30
  • Fallowfield, L., Atkins, L., Catt, S., Cox, A., Coxon, C., Langridge, C., Price, M. (2006). Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Annals of Oncology, 17(2), 205-210.
  • Esper, P. (2013). Identifying strategies to optimize care with oral cancer therapy. Clinical Journal of Oncology Nursing, 17(6), 629-636.
  • Enriquez, M., Gore Jr, P. A., C. O'Connor, M., & McKinsey, D. S. (2004). Assessment of readiness for adherence by HIV-positive males who had previously failed treatment. Journal of the Association of Nurses in AIDS Care, 15(1), 42-49.
  • Emmons, K. M., & Rollnick, S. (2001). Motivational interviewing in health care settings: Opportunities and limitations. American Journal of Preventive Medicine, 20(1), 68-74.
  • Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Verweij, J. (2009). New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer, 45(2), 228-247.
  • Edmonds, K., Hull, D., Spencer-Shaw, A., Koldenhof, J., Chrysou, M., Boers-Doets, C., & Molassiotis, A. (2012). Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group. European Journal of Oncology Nursing, 16(2), 172-184.
  • Dimatteo, M. R., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002). Patient adherence and medical treatment outcomes: a meta-analysis. Medical Care, 40(9), 794-811.
  • DiIorio, C., Reisinger, E. L., Yeager, K. A., & McCarty, F. (2009). A telephone-based self-management program for people with epilepsy. Epilepsy & Behavior, 14(1), 232-236.
  • DiIorio, C., McCarty, F., Resnicow, K., Holstad, M. M., Soet, J., Yeager, K., Lundberg, B. (2008). Using motivational interviewing to promote adherence to antiretroviral medications: A randomized controlled study. AIDS Care, 20(3), 273-283. doi: 10.1080/09540120701593489
  • DiIorio, C., Escoffery, C., McCarty, F., Yeager, K. A., Henry, T. R., Koganti, A., Wexler, B. (2009). Evaluation of WebEase: an epilepsy self-management web site. Health Education Research, 24(2), 185-197.
  • Denois, V. R., Poirson, J., Nourissat, A., Jacquin, J. P., Guastalla, J. P., & Chauvin, F. (2011). Adherence with oral chemotherapy: Results a qualitative study of behaviour and representations of patients and oncologists. European Journal of Cancer Care, 20, 520-527.
  • Decker, V., Spoelstra, S., Miezo, E., Bremer, R., You, M., Given, C., Given, B. (2009). A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents. Cancer nursing, 32(6), E20-E29.
  • Cramer, J. A., Roy, A., Burrell, A., et al. (2008). Medication compliance and persistence: Terminology and definitions Value in health, 11(1), 44-47.
  • Chau, I., Legge, S., & Fumoleau, P. (2004). The vital role of education and information in patients receiving capecitabine (Xeloda ). European Journal of Oncology Nursing, 8, Supplement 1(0), S41-S53. doi: http://dx.doi.org/10.1016/j.ejon.2004.06.008
  • Cassidy, J. (2005). Benefits and drawbacks of the use of oral fluoropyrimidines as single-agent therapy in advanced colorectal cancer. Clinical Colorectal Cancer, 5, S47-S50.
  • Campbell, M. K., Carr, C., DeVellis, B., Switzer, B., Biddle, A., Amamoo, M. A., Sandler, R. (2009). A randomized trial of tailoring and motivational interviewing to promote fruit and vegetable consumption for cancer prevention and control. Annals of Behavioral Medicine, 38(2), 71-85.
  • Briner, A., Bedell, M. K., Avery, J. T., & Ernstoff, M. S. (2006). Program to support safe administration of oral chemotherapy. Journal of Oncology Practice, 2(1), 5-6.
  • Briner, A. (2003). Safe administration of oral chemotherapy. Clinical Journal of Oncology Nursing, 7(2), 158–162.
  • Borrelli, B., Riekert, K. A., Weinstein, A., Rathier, L.(2007). Brief motivational interviewing as a clinical strategy to promote asthma medication adherence. Journal of Allergy and Clinical Immunology. 120(5). 1023-1030. DOL: doi:10.1016/j.jaci.2007.08.017
  • Bennett, J. W., & Glasziou, P. P. (2003). Computerized reminders and feedback in medication management: a systematic review of randomized controlled trials. Medical Journal of Australia, 178(5), 217-222.
  • Benjamin L., Cott , F-E., Philippe, C., Mercie,r F., Bachelot, T., & Vidal-Tr can, G. (2012). Physicians' preferences for prescribing oral and intravenous anticancer drugs: a Discrete choice experiment. European Journal of Cancer, 48(6), 912-20.
  • Bassan, F., Peter, F., Houbre, B., Brennstuhl, M., Costantini, M., Speyer, E., & Tarquinio, C. (2014). Adherence to oral antineoplastic agents by cancer patients: definition and literature review. European Journal of Cancer Care, 23(1), 22-35.
  • Barton, D. (2011). Oral agents in cancer treatment: the context for adherence. Seminars in Oncology Nursing. 27(2), 104-115.
  • Barron, T. I., Cannolly, R., Bennett, K., Freely, J., & Kennedy, M. J. (2007). Early discontinuation of tamoxifen: a lesson for oncologists. Cancer, 109, 832-839.
  • Banning, M. (2012). Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review. European Journal of Cancer Care, 21(1), 10-19. doi: 10.1111/j.1365-2354.2011.01295.x
  • Banna, G. L., Collova, E., Gebbia, V., Lipari, H., Giuffrida. P., Cavallaro. S., Condorelli, R., Buscarino, C., Tralongo, P., & Ferrau, F. (2010). Anticancer oral therapy: emerging related issues. Cancer treatment Reviews, 36(8), 595-605.
  • Amrhein, P. C., Miller, W. R., Yahne, C. E., Palmer, M., & Fulcher, L. (2003). Client commitment language during motivational interviewing predicts drug use outcomes. Journal of Consulting and Clinical Psychology, 71(5), 862.
  • Aisner, J. (2007). Overview of the changing paradigm in cancer treatment: Oral chemotherapy. American Journal of Health-System Pharmacy. 64(9), S4-S7.
  • Agboola, S., Flanagan, C., Searl, M., Elfiky, A., Kvedar, J., & Jethwani, K.(2014). Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: Study design of a randomized controlled trial. JMIR Research Protocols, 3(4), e79. doi: 10.2196/resprot.4041